Stock comparison
United Therapeutics
Wave Life Sciences
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
WVE
Wave Life Sciences
Market cap
$1.23B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | UTHR | WVE | Winner |
|---|---|---|---|
| Warren Buffett | 71B | 31F | UTHR |
| Benjamin Graham | 76B | 55D | UTHR |
| Philip Fisher | 76B | 47D | UTHR |
| Peter Lynch | 62C | 6F | UTHR |
| Joel Greenblatt | 46D | 4F | UTHR |
| Charlie Munger | 64C | 46D | UTHR |
| Terry Smith | 64C | 45D | UTHR |
Side-by-side metrics
| Metric | UTHR | WVE |
|---|---|---|
| Market cap | $24.13B | $1.23B |
| P/E (TTM) | 19.2x | - |
| EV/EBIT | 15.2x | - |
| ROIC (TTM) | 18.81% | -36.32% |
| Gross margin | 86.58% | 93.79% |
| Net margin | 40.61% | -2.56% |
| Revenue CAGR 5y | 17.22% | 1.06% |
| EPS CAGR 5y | 29.84% | - |
| Debt / Equity | - | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UTHR leads on
- ROIC (TTM)18.81%vs -36.32%+152%
- Net margin40.61%vs -2.56%+116%
- Debt / Equity-vs 0.0x+100%
- Market cap$24.13Bvs $1.23B+95%
WVE leads on
- P/E (TTM)-vs 19.2x+140%
- EV/EBIT-vs 15.2x+126%
- Gross margin93.79%vs 86.58%+8%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.